Find a Tender
complete
Official procurement procedure
UK Research and Innovation - Oligonucleotide Synthesis and Nucleic Acid Sequencing Services Framework
Peptones and protein substances
Research and development services and related consultancy services
UK
Published value
Not published
Submission deadline Not published
Lots published12
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: UK Research and Innovation: "UK Research and Innovation - Oligonucleotide Synthesis and Nucleic Acid Sequencing Services Framework". Published status: complete. Published value: Value not published. 12 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | UK Research and Innovation | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: UK Research and Innovation
Market Analytics
Derived from OCDS awards & bid statistics
Published history for UK Research and Innovation. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
17.2Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 12 active published awards; 12 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUK Research and Innovation | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published25 Jun 2024, 10:50 BST | Last source update25 Jun 2024, 10:50 BST | Recurring procurementNot published |
ClassificationPeptones and protein substances, Research and development services and related consultancy services | ||
Delivery area UK | ||
OCIDocds-h6vhtk-03f0a6 | ||
What is being bought
***This is an Award Notice, Not a Call for Competition****
This Framework has been established for the provision of UK Research and Innovation: Oligonucleotide Synthesis and Nucleic Acid Sequencing Services .
This Framework is being Established for a term of 3 years + 1 year
What changed
From the official release history
- tender value changed
25 Jun 2024, 10:50 BST - Status changed to complete
25 Jun 2024, 10:50 BST - Official notice release published
25 Jun 2024, 10:50 BST - Submission deadline changed to published date
25 Jun 2024, 10:50 BST - Buyer information updated
25 Jun 2024, 10:50 BST - Status changed to active
15 Sept 2023, 15:09 BST - Official notice release published
15 Sept 2023, 15:09 BST - Submission deadline changed to 23 Oct 2023, 10:00 BST
15 Sept 2023, 15:09 BST - Buyer information updated
15 Sept 2023, 15:09 BST - Published value updated to £8,000,000
17 Aug 2023, 13:13 BST - Status changed to planned
17 Aug 2023, 13:13 BST - Official notice release published
17 Aug 2023, 13:13 BST - Buyer information updated
17 Aug 2023, 13:13 BST
Lots and requirements (12)
Published by the contracting authority
- Lot 1 · #Sub Lot 1.1Sub Lot 1.1cancelledPublished valueNot publishedSub lot 1.1 - First Generation Nucleic Acid sequencing services For the above sub lot, UKRI wish to put in place a framework for the purchase of a range of user selectable Nucleic Acid sequencing (Sanger/ ~800-1000 base pair read) services to be provided. This could include but is not limited to the following: • Provide Phred 20 quality for as many nucleotides per sample as possible (min 800 bp or above for 5' 3' reads). • Provide purification and sequencing of plasmids and PCR products in both 1.5 ml tubes and microtiter plates (must offer 96 well as a minimum). • Provide purification and sequencing of plasmids supplied as Escherichia coli clones in both 1.5 ml tubes and microtiter plates (must offer 96 well as a minimum). • Provide sequencing services using both primers synthesized by supplier and those with user provided primers. • Provide Primer walking services in both double and single stranded DNA.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #Sub Lot 1.2Sub Lot 1.2 - Second Generation Nucleic Acid Sequencing ServicescancelledPublished valueNot publishedSub lot 1.2 - Second Generation Nucleic Acid sequencing services For the above sub lot, UKRI wish to put in place a framework for the purchase of a range of Second Generation sequencing services from a range of samples and formats including tubes, microtiter plates, preparation & extractions services including from colonies and tissue samples. A range of user selectable Nucleic Acid sequencing services are required that could include but not limited to: • Ligation or sequencing by synthesis • Pyrosequencing • Dye sequencing • Semiconductor based sequencing • Provide sample pick-up or sample mailing/courier service as required. • Provide purification and sequencing of samples supplied • Offer suitable solutions to templates failing to give readable resultsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #Sub Lot 1.3Sub Lot 1.3 - Third Generation Nucleic Acid Sequencing ServicescancelledPublished valueNot publishedSub lot 1.3 - Third Generation Nucleic Acid sequencing services For the above Sub Lot, UKRI wish to put in place a framework for the purchase of a range of Third generation sequencing services from a range of samples and formats including tubes, microtiter plates, preparation & extractions services including from colonies and tissue samples utilising novel or 'next generation technologies. A range of user selectable Nucleic Acid sequencing services are required that could include but not limited to: • PCR determination • combinatorial probe-anchor synthesis (cPAS) • fluorescently labelled antibody binding sequencing • Single-molecule real-time (SMRT) sequencing • zero-mode waveguide sequencing • sequencing of DNA via Nano pore transitionContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #Sub Lot 2.1Sub Lot 2.1 - Custom Gene fragment synthesis (sub 2000bp)cancelledPublished valueNot publishedSub lot 2.1 - Custom Gene fragment synthesis (sub 2000bp) UKRI wish to put in place a framework for the purchase of a user selectable (via supplier engagement) range of Custom Gene Synthesis (sub 2000bp). For the above sub lot, a range of user selectable additional services should be available (but are not mandatory). This could include but is not limited to the following: • Genes produced with additional synthetic Nucleotides (AGTC + XY) • Custom vector production • Codon optimized sequences - all species • Site-directed mutagenesis • Bacterial, yeast, Baculovirus and mammalian gene expression services • Complex sequence synthesis - GC rich, AT rich, complex repeats & hairpin structures and toxic sequencesContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #Sub Lot 2.2Sub Lot 2.2 - Custom Gene synthesis (2001 - 3000bp)cancelledPublished valueNot publishedUKRI wish to put in place a framework for the purchase of a user selectable (via supplier engagement) range of Custom Gene Synthesis (2001 - 3000bp). For the above sub lot, a range of user selectable additional services should be available (but are not mandatory). This could include but is not limited to the following: • Genes produced with additional synthetic Nucleotides (AGTC + XY) • Custom vector production • Codon optimized sequences - all species • Site-directed mutagenesis • Bacterial, yeast, Baculovirus and mammalian gene expression services • Complex sequence synthesis - GC rich, AT rich, complex repeats & hairpin structures and toxic sequencesContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #Sub Lot 2.3Sub Lot 2.3 - Custom Gene synthesis (3001-5000bp)cancelledPublished valueNot publishedSub Lot 2.3 - Custom Gene synthesis (3001-5000bp) UKRI wish to put in place a framework for the purchase of a user selectable (via supplier engagement) range of Custom Gene Synthesis (3001 - 5000bp). For the above sub lot, a range of user selectable additional services should be available (but are not mandatory). This could include but is not limited to the following: • Genes produced with additional synthetic Nucleotides (AGTC + XY) • Custom vector production • Codon optimized sequences - all species • Site-directed mutagenesis • Bacterial, yeast, Baculovirus and mammalian gene expression services • Complex sequence synthesis - GC rich, AT rich, complex repeats & hairpin structures and toxic sequencesContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #Sub Lot 2.4Sub Lot 2.4 - Custom Gene synthesis (5001+ bp)cancelledPublished valueNot publishedUKRI wish to put in place a framework for the purchase of a user selectable (via supplier engagement) range of Custom Gene Synthesis (5001 + bp). For the above sub lot, a range of user selectable additional services should be available (but are not mandatory). This could include but is not limited to the following: • Genes produced with additional synthetic Nucleotides (AGTC + XY) • Custom vector production • Codon optimized sequences - all species • Site-directed mutagenesis • Bacterial, yeast, Baculovirus and mammalian gene expression services • Complex sequence synthesis - GC rich, AT rich, complex repeats & hairpin structures and toxic sequencesContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 8 · #Sub Lot 3.1Sub Lot 3.1 - Gene Specific DNA MethylationcancelledPublished valueNot publishedSub Lot 3.1 - Gene Specific DNA Methylation UKRI wish to put in place a Framework for the purchase of a range of Gene Specific DNA Methylation services are required to include, but not limited to: o Perform Bisulfite modification. o Perform PCR reactions. o Perform Pyrosequencing analysis.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 9 · #Sub Lot 3.2Sub Lot 3.2 - Global DNA MethylationcancelledPublished valueNot publishedSub Lot 3.2 - Global DNA Methylation UKRI wish to put in place a Framework for the purchase of a range of global DNA methylation services are required to include, but not limited to: o LC MS DNA-methylation analysis. o ELISA that enables the direct quantitation of genomic DNA methylation. o PCR based methods e.g.; Alu and LINE1. o Methylation sensitive restriction assays e.g.; luminometric methylation assay (LUMA).Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 10 · #Sub Lot 3.3Sub Lot 3.3 - Allele QuantificationcancelledPublished valueNot publishedSub Lot 3.3 - Allele quantification UKRI wish to put in place a Framework for the purchase of a range of Allele quantification services are required to include, but not limited to: o SNP detection and quantification. o Assay development for SNP detection and quantification from pooled DNA with a defined 100bp target region in murine DNA. o Validation of the above assay. o Sample testing if required for the above assay.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 11 · #Sub Lot 4.1Sub Lot 4.1 - Synthesis of DNA OligonucleotidescancelledPublished valueNot publishedSub Lot 4.1 - Synthesis of DNA oligonucleotides. UKRI wish to put in place a framework for the purchase of a range of custom Oligonucleotide synthesis services including Custom DNA oligo's in tubes, plates and RNA/siRNA, to be user selectable via supplier engagement with a range of purification and modification options. The production of custom user defined oligonucleotides in the following ranges are required (Inc. plates). • 0.01UM bases standard • 0.05UM bases standard • 0.2UM bases standard • 1.0UM bases standard • 0.025 UM / 3OD • Microtiter platesContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 12 · #Sub Lot 4.2Sub Lot 4.2 - Synthesis of Custom RNA Oligo's (both Single and double stranded RNA oligoes, siRNA) the supply of siRNA Libraries and the production of custom SiRNA LibrariescancelledPublished valueNot publishedSub Lot 4.2 - Synthesis of Custom RNA oligo's (both Single and double stranded RNA oligoes, siRNA) the supply of siRNA Libraries and the production of custom SiRNA Libraries UKRI wish to put in place a framework for the purchase of a range of custom Oligonucleotide synthesis services including Custom DNA oligo's in tubes, plates and RNA/siRNA, to be user selectable via supplier engagement with a range of purification and modification options. The production of custom user defined oligonucleotides in the following ranges are required (Inc. plates). • 0.01UM bases standard • 0.05UM bases standard • 0.2UM bases standard • 1.0UM bases standard • 0.025 UM / 3OD • Microtiter platesContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
25 Jun 2024, 10:50 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0 - Contract active
Signed 1 May 2024, 00:00 BST · £0
Commercial outcome and competition
Awards CeGat GmbH Not published · Not published · active LIFE TECHNOLOGIES LIMITED Not published · Not published · active SOURCE BIOSCIENCE UK LIMITED Not published · Not published · active IDT DNA Not published · Not published · active EDINBURGH GENETICS LIMITED Not published · Not published · active Eurofins Genomics UK Ltd Not published · Not published · active Eurogentec Ltd Not published · Not published · active GENEWIZ UK LIMITED Not published · Not published · active Macrogen Europe Not published · Not published · active MERCK LIFE SCIENCE UK LIMITED Not published · Not published · active Randox Laboratories Ltd Not published · Not published · active Twist Bioscience Not published · Not published · active |
Contracts Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active Contract £0 · signed 1 May 2024, 00:00 BST · active |
Bid statistics bids: 10 bids: 14 bids: 15 bids: 29 bids: 14 bids: 29 bids: 8 bids: 35 bids: 10 bids: 31 electronicBids: 31 electronicBids: 10 electronicBids: 14 electronicBids: 15 electronicBids: 29 electronicBids: 14 electronicBids: 29 electronicBids: 8 electronicBids: 35 electronicBids: 10 bids: 6 (lot Sub Lot 1.1) electronicBids: 6 (lot Sub Lot 1.1) bids: 5 (lot Sub Lot 1.3) electronicBids: 5 (lot Sub Lot 1.3) |
Buyer and organisations in this procedure
UK Research and Innovation
Contracting authority GB-FTS-90451Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published